IE34187L - ß-ADRENOLYTICALLY ACTIVE COMPOSITIONS - Google Patents

ß-ADRENOLYTICALLY ACTIVE COMPOSITIONS

Info

Publication number
IE34187L
IE34187L IE700439A IE43970A IE34187L IE 34187 L IE34187 L IE 34187L IE 700439 A IE700439 A IE 700439A IE 43970 A IE43970 A IE 43970A IE 34187 L IE34187 L IE 34187L
Authority
IE
Ireland
Prior art keywords
alkyl
hydroxy
hydroxyalkyl
those
group
Prior art date
Application number
IE700439A
Other versions
IE34187B1 (en
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of IE34187L publication Critical patent/IE34187L/en
Publication of IE34187B1 publication Critical patent/IE34187B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1305644 #-Adrenolytic medicines BOEHRINGER INGELHEIM GmbH 16 April 1970 [16 April 1969] 18243/70 Heading A5B Pharmaceutical compositions having improved #-adrenolytic activity comprise a #- receptor blocking agent of the 1-aryloxy-2- hydroxy-3-aminopropane or 1-aryl-1-hydroxy- 2-amino-methane type and a "minor tranquilizer". The #-adrenolyties are those of the general formula: Ar-OCH 2 -CHOH-CH 2 - NHR wherein Ar is an iso-, homo- or heterocyclic group which contains at least one 6- membered aromatic ring linked directly to the remainder of the molecule and which may optionally be substituted by one or more C 1-4 alkyl, alkoxy, alkenyl, alkenyloxy, alkynyl, alkylnyloxy, alkylthio, alkylsuphonyl, hydroxyalkyl, aminoalkyl, alkylamino, dialkylamino, acyl, acyloxy, acylamino, phenyl, phenoxy, phenylamino, phenylthio, phenylsulphonyl, phenylsulphonylamino, benzoylamino, phenalkoxy, haloalkyl, alkoxyalkyl, monoalkylaminoalkyl or dialkylaminoalkyl, nitro, hydroxy, amino, cyano or halogeno groups and R is a C 1-8 alkyl or hydroxyalkyl groups and those of the general formula: Ar 1 -CHOHCHR 1 ,-NHR wherein Ar 1 is a phenyl, naphthyl, tetralyl or indanyl group optionally substituted by halo, nitro, alkyl or alkoxy groups, R is a C 1-8 alkyl or hydroxyalkyl group and R 1 is hydrogen or a C 1-4 alkyl group. Suitable tranquilizers are those which are non-hypnotic and show no antipsychotic effect and include Hydroxyzine, Methylpentynol, Mephenesin, Mephenesin carbamate, Guiaphenesin, Meprobamate, Prenderol, Carisoprodol, Mebutamate, Chlordiazepoxide, Diazepam. Nitrazepam, Medazepam and Oxazepam. The compositions may be in conventional forms for oral, rectal and parenteral administration. [GB1305644A]
IE439/70A 1969-04-16 1970-04-07 Improvements in compositions having beta-adrenolytic activity IE34187B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19691919342 DE1919342A1 (en) 1969-04-16 1969-04-16 Cardiac active combination preparations

Publications (2)

Publication Number Publication Date
IE34187L true IE34187L (en) 1970-10-16
IE34187B1 IE34187B1 (en) 1975-03-05

Family

ID=5731393

Family Applications (1)

Application Number Title Priority Date Filing Date
IE439/70A IE34187B1 (en) 1969-04-16 1970-04-07 Improvements in compositions having beta-adrenolytic activity

Country Status (8)

Country Link
BE (1) BE748820A (en)
CA (1) CA940048A (en)
DE (1) DE1919342A1 (en)
FR (1) FR2042334B1 (en)
GB (1) GB1305644A (en)
IE (1) IE34187B1 (en)
NL (1) NL7005435A (en)
ZA (1) ZA702530B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000282A (en) 1974-12-16 1976-12-28 Merck & Co., Inc. 2-(3-tert. butyl or isopropylamino-2-hydroxypropoxy)-3-cyanopyridines
LU76150A1 (en) * 1976-11-08 1978-07-10
FR2401661A1 (en) * 1977-08-29 1979-03-30 Italiana Med Sint Compsns. for treating anxiety and neurodystonic states - contain a synergistic mixt. of benzodiazepine anxiolytic and beta adrenergic receptor inhibitor
US4279913A (en) * 1978-01-04 1981-07-21 Merck & Co., Inc. Polysubstituted-2-(3-loweralkylamino-2-R1 O-propoxy)pyridines
US4294969A (en) * 1979-01-29 1981-10-13 Merck & Co., Inc. Process for producing 2-bromo-3,5-disubstituted pyridines
DE2926653A1 (en) * 1979-07-02 1981-01-22 Sandoz Ag NEW THERAPEUTIC USE OF ORGANIC COMPOUNDS
US4416735A (en) 1982-06-17 1983-11-22 Eastman Kodak Company Diluent and method for potentiometric assay of liquids
US4468391A (en) * 1982-06-25 1984-08-28 Ayerst, Mckenna & Harrison, Inc. Combination of β-adrenoceptor antagonists and anxiolytic agents

Also Published As

Publication number Publication date
FR2042334A1 (en) 1971-02-12
FR2042334B1 (en) 1974-08-30
DE1919342A1 (en) 1970-12-03
GB1305644A (en) 1973-02-07
ZA702530B (en) 1971-01-27
BE748820A (en) 1970-10-12
IE34187B1 (en) 1975-03-05
NL7005435A (en) 1970-10-20
CA940048A (en) 1974-01-15

Similar Documents

Publication Publication Date Title
ID26179A (en) BENZENASULFONAMIDA DERIVES AND ITS USE AS MEDICINES
NO963053L (en) Cosmetic or pharmaceutical preparations containing mangiferin or derivatives thereof
MY127537A (en) Novel amidine deirvatives,their preparation and applicantion as medicines and pharmaceutical compositions
DE69532031D1 (en) MEDIA CONTAINING THYROID HORMONES
ES8308311A1 (en) Benzazepines, process for their preparation and their application as pharmaceutical preparations.
DE59009074D1 (en) Diaryl-substituted heterocyclic compound, its preparation and pharmaceuticals and cosmetics made therefrom.
TR200003524T2 (en) Use of compounds to increase pyruvate dehydrogenase activity
MY127718A (en) Dolastatin 10 derivatives.
IE34187L (en) ß-ADRENOLYTICALLY ACTIVE COMPOSITIONS
BR9712816A (en) Benzamidine derivatives and their use as drugs with an ltb4 antagonistic activity
HUT65351A (en) Process for preparing ethanolamine derivatives haring sympathominetic and anti-pollakiuria activity and pharmaceutical compositions containing them as active agent
HUP0102369A2 (en) Amino acid derivatives and drugs containing the same as the active ingredient
ATE59033T1 (en) N-CONTAINING HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THEM.
ATE69228T1 (en) AMIDA COMBINATIONS.
GB1198459A (en) Substituted 2-Amino and 2-Nitrobenzamides and preparation thereof
HU910784D0 (en) Process for producing new urea derivatives as well as pharmaceutical preparatives containing these compounds as active substance
HUP9701293A2 (en) New salts without unsavoury taste and pharmaceutical compositions containing them
HUP0104533A2 (en) Novel pyrimidine derivatives and processes for the preparation thereof and medicaments containing them
TR199900013T2 (en) New bracelets.
HUP0300573A2 (en) Triazole compounds having amide linkage and pharmaceutical compositions containing them
NO301760B1 (en) Pharmacologically active <alfa> - [tertiary aminomethyl] benzene methanol derivatives, pharmaceutical compositions containing them and use of the compounds for the preparation of pharmaceutical preparations
CA2294581A1 (en) Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
ES2170168T3 (en) COMPOSITIONS ENTIRELY COVERED FROM 1,5-BENZODIACEPIN DERIVATIVES WITH ANTIGONIST OR AGONIST ACTIVITY OF CCK.
ES2027492A6 (en) 3,4-Di-(hydro)-2H,6H-pyrimido not 2,1-b not 1,3 thiazine derivatives and 1,2,3,4-tetra-(hydro)-pyrimidin-2-thiones, process for their preparation and medicament containing them
HUP9901348A2 (en) 2-[2-[(2-hydroxyethyl)amino]ethyl]-5-[[2-methylamino)ethyl]amino]indazolo[4,3-gh]isoquinolin-6(2h)-one as antitumor agent, use and production thereof, intermediates and medicaments containing the same